Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:

Spotify (SPOT) - Get Report : "Let's take a long-term view. This stock is a buy."

Alkermes (ALKS) - Get Report : "I think this one is a buy. I also like Johnson & Johnson (JNJ) - Get Report ."

Sorrento Therapeutics (SRNE) - Get Report : "This is the kind of speculative stock that I like."

Geron (GERN) - Get Report : "Let's stick with high quality like Thermo Fisher Scientific (TMO) - Get Report ."

Kohlberg Kravis Roberts (KKR) - Get Report : "I'm a buyer. I've respected them for generations. "

Mitek Systems (MITK) - Get Report : "This one is too speculative for me. I'd buy NVIDIA (NVDA) - Get Report ."

AK Steel Holding (AKS) - Get Report : "They're not the lo- cost producer. That's Nucor (NUE) - Get Report and that's the way you want to go."

Sage Therapeutics (SAGE) - Get Report : "Let's wait and see. I can't bless it until I see more from them."

AbbVie (ABBV) - Get Report : "I want to stay away from controversy. I like Eli Lilly (LLY) - Get Report ."

Cramer and the AAP team note that seven of the companies in their portfolio are reporting this week, including Abbott Laboratories (ABT) - Get Report , Nucor (NUE) - Get Report and Honeywell (HON) - Get Report . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Over on Real Money, Cramer says if you're sitting on a down-and-out stock with a real bad chart, you need to hold on at this point because an analyst or a quarter could come to your rescue. Get more of his insights with a free trial subscription to Real Money.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in ABT, NUE, HON, NVDA, LLY.